Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06003660 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral, Chemosensory and Trigeminal Functions in Allo-HSCT

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 30, 2025 to Dec 30, 2026
    • Study completion date: Jun 30, 2026 to Mar 1, 2028
    • Study title shortened, about 2 words
    v4
  2. Primary completion date: Dec 30, 2024 to Dec 30, 2025
    • Study completion date: Jun 30, 2025 to Jun 30, 2026
    • Site details revised
    v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research team hypothesizes that treatment with allo-HSCT will induce: * Distortion of taste and smell and trigeminal functions like cooling, tingling, and burning sensations. * Reduced saliva production leading to oral dryness and dental caries. * Changes in the connectivity of the taste-, smell- and pain-cortical brain regions.
Trial Details
NCT Number NCT06003660
Lead Sponsor University of Oslo
Conditions
(from sponsor)		 Hematopoietic Stem Cell Transplantation
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov